| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000024045 |
| Receipt No. | R000027690 |
| Official scientific title of the study | The effect of L-glutamine on oral mucositis induced by chemoradiotherapy in patients with head and neck cancer. |
| Date of disclosure of the study information | 2016/10/01 |
| Last modified on | 2016/09/14 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The effect of L-glutamine on oral mucositis induced by chemoradiotherapy in patients with head and neck cancer. | |
| Title of the study (Brief title) | The effect of L-glutamine on oral mucositis induced by chemoradiotherapy in patients with head and neck cancer. | |
| Region |
|
|
| Condition | |||
| Condition | Head and neck cancer. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate of efficacy of enteral supplementation product enriched with L-glutamine in patients with head and neck cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | CTCAE score for inflammation of oral pharyngeal mucosa. |
| Key secondary outcomes | 1)Physical measurement
Body weight, Lean body weight, body fat mass, Grip strength 2)Digestive symptom oral mucositis, taste disturbance, diarrhea, appetite 3)score of Quality of life(QOL) EORT-QLQ-C30 4)Blood test Alb,TP,PA,RBP,serum diamine oxidase activity,IL-6,active ghrelin 5)Amount of total Energy by oral feeding, enteral feeding, parenteral nutrition 6)Duration and dosage of opioid. 7)Rate of CRT completion. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | L-glutamine group: L-glutamine(1-3 pack per day) from 4days before to end of CRT. | |
| Interventions/Control_2 | Control group: Placebo(1-3 pack per day) from 4days before to end of CRT. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Aged >= 20
2) Patients with head and neck cancer. 3) Patients who receive chemoradiotherapy. 4) Recovered from previous chemotherapy and radiotherapy toxicities. 5) Patients who obtained the consent. |
|||
| Key exclusion criteria | 1)Unable intake glutamine formulations per oral or per enteral tube.
2)major impairment of liver 3)major impairment of kidney 4)allergic to L-glutamine 5)pregnant,lactating 6)presence of other cancer under treatment. 7)severe psychosis or psychiatric symptoms 8)paticipation judged by physician to be inadvisable 9)paticipation not taking opioids |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Mika Kurihara |
| Organization | Shiga University of Medical Science Hospital |
| Division name | Clinical nutrition |
| Address | Seta Tsukinowa-cho, Otsu-city, Shiga, Japan 520-2192 |
| TEL | 077-548-2519 |
| kuri@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Mai Inoue |
| Organization | Shiga University of Medical Science Hospital |
| Division name | Clinical nutrition |
| Address | Seta Tsukinowa-cho, Otsu-city, Shiga, Japan 520-2192 |
| TEL | 077-548-2519 |
| Homepage URL | |
| maiapril@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aido Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027690 |